Mineralys Therapeutics (MLYS) Financials: Revenue & Earnings

MLYS price $21.12 -0.01 -0.05%

Ticker
MLYS
Price
$21.12
Change
-0.01 -0.05%
Market cap ?
$1.87B
P/E ?
-4.98
Forward P/E ?
11.12
Dividend yield ?
0.00%
Beta ?
0.69
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
57
Quality
46
Growth
84

Stocklytics score rationale: value 57, quality 46, growth 84.

Financials

202020212022202320242025
000000

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally…

Fair value

MLYS fair value $74.45. Price $21.12. Price is 72% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare MLYS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.55——
2026-08-12-2.85-0.55——
2026-05-06-0.47-0.51——
2026-03-12-0.40-0.52——
2025-11-10-0.52-0.66——
2025-08-12-0.66-0.78——
2025-05-12-0.79-1.02——
2025-02-12-0.98-1.00——
2024-11-11-1.13-0.83——
2024-08-13-0.83-0.73——
2024-05-09-0.70-0.68——
2024-03-21-0.61-0.85——
2023-11-07-0.57-0.72——
2023-08-07-0.31-0.83——
2023-05-15-0.51-0.71——
2023-03-15-1.741.72——
2023-02-10-1,288.84———
2022-06-30-0.35———
2022-03-31-0.41———
2021-12-31-0.18———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-19Peterson KristineBuy16.60K$20.92347.27K
2026-10-19Peterson KristineBuy12.40K——
2026-10-19Peterson KristineOther0——
2026-10-19COATS LONNELBuy16.60K$20.92347.27K
2026-10-19COATS LONNELBuy12.40K——
2026-10-19COATS LONNELOther0——
2026-09-30Congleton JonSell75.00K$25.461.91M
2026-09-22Slingsby Brian TaylorSell104.32K$28.813.01M
2026-09-21Warren EricSell7.44K$13.2498.48K
2026-09-21Warren EricBuy7.44K$13.2498.48K
2026-09-21Warren EricSell7.44K$28.12209.14K
2026-09-15Karydas DaphneSell3.00K$12.0236.06K
2026-09-15Karydas DaphneBuy3.00K$12.0236.06K
2026-09-15Karydas DaphneSell3.00K$28.5885.74K
2026-08-21Warren EricSell7.44K$13.2498.47K
2026-08-21Warren EricBuy7.44K$13.2498.47K
2026-08-21Warren EricSell7.44K$25.98193.19K
2026-08-10Ferguson James J. IIIBuy135.00K$27.383.70M
2026-08-10Ferguson James J. IIIBuy102.40K——
2026-08-10Ferguson James J. IIIOther0——
2026-08-10Rodman David MalcomBuy2.17K$16.0034.72K
2026-08-10Rodman David MalcomSell2.17K$27.0958.79K
2026-08-10Rodman David MalcomSell2.17K$16.0034.72K
2026-07-21Warren EricSell7.44K$13.2498.48K
2026-07-21Warren EricBuy7.44K$13.2498.48K
2026-07-21Warren EricSell7.44K$26.87199.89K
2026-07-17Rodman David MalcomBuy416$15.446.42K
2026-07-17Rodman David MalcomSell416$26.5311.04K
2026-07-17Rodman David MalcomSell416$15.446.42K
2026-07-15Rodman David MalcomSell6.35K$26.61168.95K
2026-07-13Congleton JonSell10.70K$27.24291.44K
2026-07-13Rodman David MalcomSell3.54K$10.2036.13K
2026-07-13Rodman David MalcomSell4.17K$14.2559.38K
2026-07-13Rodman David MalcomBuy6.35K$1.086.86K
2026-07-13Rodman David MalcomBuy4.17K$14.2559.38K
2026-07-13Rodman David MalcomBuy3.54K$10.2036.13K
2026-07-13Rodman David MalcomSell14.06K$27.58387.72K
2026-07-13Rodman David MalcomSell6.35K$1.086.86K
2026-07-09Rodman David MalcomBuy2.17K$16.0034.74K
2026-07-09Rodman David MalcomSell2.17K$30.3065.78K
2026-07-09Rodman David MalcomSell2.17K$16.0034.74K
2026-06-30Congleton JonSell58.00K$25.941.50M
2026-06-30Congleton JonSell17.00K$26.82455.90K
2026-06-26Warren EricSell104.12K$13.241.38M
2026-06-26Warren EricBuy104.12K$13.241.38M
2026-06-26Warren EricSell104.12K$25.902.70M
2026-06-17Rodman David MalcomSell4.17K$14.2559.38K
2026-06-17Rodman David MalcomBuy417$15.446.44K
2026-06-17Rodman David MalcomBuy4.17K$14.2559.38K
2026-06-17Rodman David MalcomSell4.58K$25.00114.60K
2026-06-17Rodman David MalcomSell417$15.446.44K
2026-06-17Karydas DaphneSell3.00K$12.0236.06K
2026-06-17Karydas DaphneBuy3.00K$12.0236.06K
2026-06-17Karydas DaphneSell3.00K$25.0075.00K
2026-06-15Rodman David MalcomSell3.54K$10.2036.13K
2026-06-15Rodman David MalcomBuy3.54K$10.2036.13K
2026-06-15Rodman David MalcomSell9.89K$23.81235.49K
2026-06-12Rodman David MalcomBuy6.35K$1.086.86K
2026-06-12Rodman David MalcomSell6.35K$23.93151.90K
2026-06-12Rodman David MalcomSell6.35K$1.086.86K
2026-06-10Rodman David MalcomBuy2.17K$16.0034.72K
2026-06-10Rodman David MalcomSell2.17K$25.0054.25K
2026-06-10Rodman David MalcomSell2.17K$16.0034.72K
2026-05-18Rodman David MalcomBuy417$15.446.44K
2026-05-18Rodman David MalcomSell417$27.5511.49K
2026-05-18Rodman David MalcomSell417$15.446.44K
2026-05-13Rodman David MalcomSell3.54K$10.2036.12K
2026-05-13Rodman David MalcomSell4.17K$14.2559.37K
2026-05-13Rodman David MalcomBuy4.17K$14.2559.37K
2026-05-13Rodman David MalcomBuy3.54K$10.2036.12K
2026-05-13Rodman David MalcomSell14.06K$28.58401.79K
2026-05-12Rodman David MalcomBuy6.35K$1.086.86K
2026-05-12Rodman David MalcomSell6.35K$29.36186.35K
2026-05-12Rodman David MalcomSell6.35K$1.086.86K
2026-05-11Rodman David MalcomBuy2.17K$16.0034.74K
2026-05-11Rodman David MalcomSell2.17K$29.7164.50K
2026-05-11Rodman David MalcomSell2.17K$16.0034.74K
2026-04-17Rodman David MalcomBuy416$15.446.42K
2026-04-17Rodman David MalcomSell416$31.3313.03K
2026-04-17Rodman David MalcomSell416$15.446.42K
2026-04-15Rodman David MalcomSell6.35K$27.66175.59K
2026-04-13Rodman David MalcomSell3.54K$10.2036.13K
2026-04-13Rodman David MalcomSell4.17K$14.2559.38K
2026-04-13Rodman David MalcomBuy4.17K$14.2559.38K
2026-04-13Rodman David MalcomBuy3.54K$10.2036.13K
2026-04-13Rodman David MalcomBuy6.35K$1.086.86K
2026-04-13Rodman David MalcomSell14.06K$26.54373.09K
2026-04-13Rodman David MalcomSell6.35K$1.086.86K
2026-04-13Congleton JonSell15.73K$26.83421.98K
2026-04-09Rodman David MalcomBuy2.17K$16.0034.72K
2026-04-09Rodman David MalcomSell2.17K$27.3859.41K
2026-04-09Rodman David MalcomSell2.17K$16.0034.72K
2026-03-31Congleton JonSell19.36K$25.50493.79K
2026-03-31Congleton JonSell55.18K$26.541.46M
2026-03-31Congleton JonSell453$27.0512.25K
2026-03-31Karydas DaphneSell3.00K$12.0236.06K
2026-03-31Karydas DaphneBuy3.00K$12.0236.06K
2026-03-31Karydas DaphneSell3.00K$25.0075.00K
2026-03-30RA CAPITAL MANAGEMENT, L.P.Buy58.30K$24.161.41M
2026-03-27RA CAPITAL MANAGEMENT, L.P.Buy310.70K$23.677.35M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 242, holders +12 vs prior quarter. Ownership 120.97%.

HolderSharesChangeChange %Value
CATALYS PACIFIC, LLC7.90M00.00%213.25M
RA CAPITAL MANAGEMENT, L.P.7.69M00.00%207.55M
BLACKROCK, INC.5.89M1.41M+31.36%158.83M
SAMSARA BIOCAPITAL, LLC5.87M00.00%158.40M
FMR LLC4.51M-349.42K-7.19%121.73M
STATE STREET CORP4.14M1.21M+41.07%111.74M
DEERFIELD MANAGEMENT COMPANY, L.P.3.96M3.96MNew106.79M
VANGUARD CAPITAL MANAGEMENT LLC2.76M302.41K+12.32%74.38M
LAURION CAPITAL MANAGEMENT LP2.51M274.11K+12.28%67.62M
PRICE T ROWE ASSOCIATES INC /MD/2.26M919.16K+68.43%61.04M
ORBIMED ADVISORS LLC2.11M57.40K+2.80%56.94M
CAPITAL WORLD INVESTORS2.00M1.60M+401.69%53.90M
ARMISTICE CAPITAL, LLC1.74M560.00K+47.62%46.84M
TROLUCE CAPITAL ADVISORS LLC1.73M1.07M+163.93%46.64M
FRANKLIN TEMPLETON INC1.64M-149.14K-8.36%44.13M
ANDERA PARTNERS1.59M00.00%42.95M
GEODE CAPITAL MANAGEMENT, LLC1.58M283.19K+21.76%42.75M
SR ONE CAPITAL MANAGEMENT, LP1.56M00.00%42.20M
BANK OF AMERICA CORP /DE/1.51M405.18K+36.82%40.62M
SPHERA FUNDS MANAGEMENT LTD.1.47M130.00K+9.70%39.66M
GOLDMAN SACHS GROUP INC1.46M673.63K+85.81%39.36M
PICTET ASSET MANAGEMENT HOLDING SA1.43M396.21K+38.30%38.60M
POLAR CAPITAL HOLDINGS PLC1.42M-79.89K-5.32%38.33M
MILLENNIUM MANAGEMENT LLC1.22M696.50K+132.60%32.96M
GHISALLO CAPITAL MANAGEMENT LLC1.12M1.12MNew30.35M

Earnings and financials

Mineralys Therapeutics, Inc. (MLYS) trades at $21.12, with a market cap of $1.87B and a trailing P/E of -4.98. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

202020212022202320242025
000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Mineralys Therapeutics (MLYS) Financials: Revenue & Earnings

MLYS$21.12-0.01 -0.05%

$1.87B

Market Cap

-4.98

P/E

11.12

Forward P/E

62

Score

Price History